Welcome to the InfoSci Platform
Biopharma Innovation Models for Gulf Region in the Era of Globalisation

Biopharma Innovation Models for Gulf Region in the Era of Globalisation

Rakhi Rashmi
Copyright: © 2015 |Pages: 30
ISBN13: 9781466673328|ISBN10: 146667332X|EISBN13: 9781466673335
DOI: 10.4018/978-1-4666-7332-8.ch010
Cite Chapter Cite Chapter

MLA

Rashmi, Rakhi. "Biopharma Innovation Models for Gulf Region in the Era of Globalisation." Organizational Innovation and IT Governance in Emerging Economies, edited by Jingyuan Zhao, et al., IGI Global, 2015, pp. 195-224. https://doi.org/10.4018/978-1-4666-7332-8.ch010

APA

Rashmi, R. (2015). Biopharma Innovation Models for Gulf Region in the Era of Globalisation. In J. Zhao, P. Ordóñez de Pablos, & R. Tennyson (Eds.), Organizational Innovation and IT Governance in Emerging Economies (pp. 195-224). IGI Global. https://doi.org/10.4018/978-1-4666-7332-8.ch010

Chicago

Rashmi, Rakhi. "Biopharma Innovation Models for Gulf Region in the Era of Globalisation." In Organizational Innovation and IT Governance in Emerging Economies, edited by Jingyuan Zhao, Patricia Ordóñez de Pablos, and Robert D. Tennyson, 195-224. Hershey, PA: IGI Global, 2015. https://doi.org/10.4018/978-1-4666-7332-8.ch010

Export Reference

Mendeley
Favorite

Abstract

Biopharmaceutical is the most upcoming segment of the pharmaceutical industry as the use of biotechnology has the potential to provide cures for the most life threatening and difficult ailments. At the same time for biopharma innovation, factors such as increasing costs, high continuous funding, and risk funding are of increasing concern for the emerging economies. This chapter measures the strength of biopharma innovation indicators in Gulf Cooperation Council (GCC) and explores the potential biopharma innovation models for gulf countries.

Request Access

You do not own this content. Please login to recommend this title to your institution's librarian or purchase it from the IGI Global bookstore.